Journal of Antimicrobial Chemotherapy (1987) 20, 7-13
© 1987 The British Society for Antimicrobial Chemotherapy
research-article |
Covalent trapping and latamoxef resistance in ß-lactamase-derepressed Pseudomonas aeruginosa
Department of Medical Microbiology, London Hospital Medical College Turner Street, London E1 2AD, UK
accepted 15 February 1987
Three Pseudomonas aeruginosa strains which constitutively produced chromosomal (Id, or Sabath and Abraham) ß-lactamase in large amounts were resistant to latamoxef (moxalactam) MICs, 128256 mg/l). Their ß-lactamase-basal mutants, which produced 120018,000-fold less enzyme, were latamoxef-sensitive (MICs, 416 mg/l), suggesting that the enzyme caused the resistance of the parent organisms. Latamoxef was a feeble substrate of the enzyme (kcal <0.5/min) but reacted to form a stable complex that lacked catalytic activity against benzylpenicillin. The complex was isolated by gel filtration and was shown to be stable to isoelectric focusing, suggesting a covalent link between the enzyme and latamoxef. During incubation the complex underwent a slow breakdown, regenerating active enzyme. This breakdown obeyed first-order kinetics, and the half-life of the inactivated form was 19±1min at 37°C. Binding of antibiotic molecules in this complex may contribute to the latamoxef-resistance observed in the ß-lactamase-derepressed strains. This covalent trapping should be distinguished from the non-covalent trapping proposed elsewhere as a general mechanism of ß-lactamase-mediated resistance to reversibly-bound weak-substrate ß-lactams.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
V. S. Lucas, A. Kyriazidou, M. Gelbier, and G. J. Roberts Bacteraemia following debanding and gold chain adjustment Eur J Orthod, April 1, 2007; 29(2): 161 - 165. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.J. Todd, S.J. Leslie, M. MacDougall, and M.A. Denvir Clinical features remain important for the diagnosis of infective endocarditis in the modern era QJM, January 1, 2006; 99(1): 23 - 31. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.F.N. Koegelenberg, A.F. Doubell, H. Orth, and H. Reuter Infective endocarditis in the Western Cape Province of South Africa: a three-year prospective study QJM, March 1, 2003; 96(3): 217 - 225. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. S. Lucas, V. Lytra, T. Hassan, H. Tatham, M. Wilson, and G. J. Roberts Comparison of Lysis Filtration and an Automated Blood Culture System (BACTEC) for Detection, Quantification, and Identification of Odontogenic Bacteremia in Children J. Clin. Microbiol., September 1, 2002; 40(9): 3416 - 3420. [Abstract] [Full Text] [PDF] |
||||
![]() |
R O-M Netzer, E Zollinger, C Seiler, and A Cerny Infective endocarditis: clinical spectrum, presentation and outcome. An analysis of 212 cases 1980-1995 Heart, July 1, 2000; 84(1): 25 - 30. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Delahaye, M.-O. Rial, G. de Gevigney, R. Ecochard, and J. Delaye A critical appraisal of the quality of the management of infective endocarditis J. Am. Coll. Cardiol., March 1, 1999; 33(3): 788 - 793. [Abstract] [Full Text] [PDF] |
||||




